ChemoCentryx: Detailed Company Information & Corporate Profile
Summary
ChemoCentryx, founded in 1997 and headquartered in San Carlos, California, is an independent biotech company focused on biopharmaceutical development for autoimmune diseases, inflammatory disorders, and rare conditions.
The company’s portfolio includes therapies for ANCA‑associated vasculitis, Hidradenitis Suppurativa, Chronic Kidney Disease, Diabetic Nephropathy, Pancreatic Cancer, C3 Glomerulopathy, Inflammatory Bowel Disease, Rheumatoid Arthritis, and complementary receptor–targeted agents such as Avacopan.
ChemoCentryx develops both biologic and small‑molecule therapeutics, leveraging a chemoattractant system platform for novel anti‑inflammatory drugs.
With 100–200 employees and annual revenues between $10 million and $50 million, the firm’s senior leadership includes Executive Vice President Susan Kanaya, Director Wen Zhang, and other key scientific and operational personnel.
| ChemoCentryx Website | chemocentryx.com |
| Social Links |    |
| Phone Number | 650.210.2900 |
| Industries | |
| ChemoCentryx Headquarters Address | 835 Industrial Road, San Carlos, California, 94070 US |
| Company Size | 100-200 employees |
| Specialities & Services | Biopharmaceutical, autoimmune diseases, inflammatory disorders, orphan and rare diseases, ANCA-associated vasculitis, oral therapeutics, immuno-oncology, Hidradenitis Suppurativa, Chronic Kidney Disease, Diabetic Nephropathy, Pancreatic Cancer, C3 Glomerulopathy, Small Molecule Therapeutics, Chemoattractant System, Chemokine, Drug Discovery, Inflammatory Bowel Disease (IBD), Rheumatoid Arthritis (RA), Avacopan, Complement Receptor, ADVOCATE, AURORA, LUMINA, TAVNEOS |
| SIC Code | 2834 |
| NAICS Code | 325412 Pharmaceutical Preparation Manufacturing |
| DMA Code | San Francisco Bay Area |
| Founded | 1997 |
| Estimated Annual Revenue | $10M - 50M |
| Operating Status | Independent Company |
| Updated: | 2026-10-01 |
Competitors
Name | Founded | Type | Employees |
|---|---|---|---|
| 1979 | Public Company | 250 - 500 | |
| 2013 | Public Company | 100 - 250 | |
| 2000 | Public Company | 25 - 100 | |
| 2014 | Public Company | 25 - 100 |
Workforce Turnover
Length of Employment
ChemoCentryx's workforce includes employees across a wide range of tenure levels.
8% have been with the company for 3 to 4 years12% have been with the company for 5 to 7 years12% have been with the company for 8 to 10 years68% have been with the company for more than 11 years
Companies Similar to ChemoCentryx
ChemoCentryx Corporate Information: FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
